{
    "Trade/Device Name(s)": [
        "ACE Carbon Dioxide (CO2-LC) Reagent",
        "ACE Direct Bilirubin Reagent",
        "ACE Total Bilirubin Reagent",
        "ACE Magnesium Reagent"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K123953",
    "Predicate Device Reference 510(k) Number(s)": [
        "K931786"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS",
        "CIG",
        "JGJ"
    ],
    "Summary Letter Date": "May 2, 2013",
    "Summary Letter Received Date": "March 25, 2013",
    "Submission Date": "March 22, 2013",
    "Regulation Number(s)": [
        "21CFR862.1160",
        "21CFR862.1110",
        "21CFR862.1495"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system",
        "Bilirubin (total and direct) test system",
        "Magnesium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon dioxide",
        "Direct bilirubin",
        "Total bilirubin",
        "Magnesium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Clinical Chemistry System",
        "ACE Alera Clinical Chemistry System",
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric",
        "Enzymatic (for CO2)",
        "Diazo colorimetry (for bilirubin)",
        "Photometric method (for magnesium)"
    ],
    "Methodologies": [
        "Enzymatic quantification",
        "Diazo colorimetry",
        "Photometric quantification"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ACE chemistry reagents for carbon dioxide, direct bilirubin, total bilirubin, and magnesium determinations on ACE, ACE Alera, and ACE Axcel clinical chemistry analyzers",
    "Indications for Use Summary": "Intended for quantitative determination of carbon dioxide, direct bilirubin, total bilirubin, or magnesium in serum and lithium heparin plasma using ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems; aids diagnosis and treatment of acid-base, liver, hematological, metabolic, and magnesium disorders; for clinical or physician office lab use only.",
    "fda_folder": "Clinical Chemistry"
}